logo
    Physiologic jaundice of the newborn: animal models of perinatal development.
    PubMed (1993)
    Lawrence M. GartnerEstella M. Alonso
    1
    Citation
    0
    Reference
    10
    Related Paper
    Keywords:
    Animal model
    Topics:
    Infant Nutrition and Health
    Neonatal Health and Biochemistry
    Digestive system and related health
    Respiratory distress syndrome of newborn infants
    The Journal of Pediatrics (1962)
    Herbert C. Miller
    Citations (19)
    [Therapy of congenital primary hypothyroidism in the infant age].
    PubMed (1977)
    Ferdinand HaschkeL HohenauerHans G. Feichtinger
    Congenital hypothyroidism
    Primary (astronomy)
    Citations (0)
    Phototherapy in Nonobstructive, Nonhemolytic Jaundice
    PEDIATRICS (1973)
    Çiğdem AltayBurhan Say
    An infant with Crigler-Najjar syndrome of Arias Type I has been presented and the efficiency of light therapy is discussed.
    Citations (10)
    Evaluation of the causes of neonatal jaundice, based on the infant’s age at disease onset and age at hospital admission
    DOAJ (DOAJ: Directory of Open Access Journals) (2016)
    Hassan BoskabadiMaryam ZakerihamidiFatemeh BagheriAbbas Boskabadi
    Citations (2)
    [A 29-year-old male with jaundice, abdominal pain and distension after a transplant of allogeneic bone marrow for acute leukemia].
    PubMed (1986)
    Pons Romero FMiquel BrugueraBombí Ja
    Abdominal distension
    Bone marrow transplant
    Citations (0)
    [Surgical treatment of constrictive pericarditis and postoperative jaundice].
    PubMed (1988)
    Qiu Ny
    Citations (0)
    Acute severe jaundice in a young patient.
    PubMed (1990)
    Olm MManuel PeraJ. FustérValdecasas JcJ. Visa
    Citations (1)
    Fat Embolism and Postoperative Jaundice
    JAMA (1975)
    Richard W. Rasmussen
    THE FAT embolism syndrome is generally considered to be uncommon except as a complication of fractures or severe trauma.1Evidence is accumulating that, in mild form, this phenomenon may be frequent and may even follow minor injury.2,3We recently saw a patient in whom the fat embolism syndrome developed after minor surgery. Furthermore, jaundice, which is not usually observed in patients with fat embolism, was a major feature.

    Report of a Case

    A muscular 20-year-old man underwent anterior capsule repair for chronic dislocation of the shoulder. He had been in excellent health, took no medication, and gave no prior history of liver disease. The operation, under halothane anesthesia, lasted 21/2 hours. There were no periods of hypotension. Blood loss was minimal and transfusions were not given. At 48 hours after operation, pyrexia to 40.5 C (105 F) developed. He became dyspneic and complained of moderately severe upper
    Fat embolism syndrome
    Air embolism
    Citations (0)
    Jaundice and agranulocytosis with fatality following chlorpromazine therapy.
    JAMA (1955)
    Hodges HhLazerte Gd
    Citations (25)
    AARC Clinical Practice Guideline: Effectiveness of Pharmacologic Airway Clearance Therapies in Hospitalized Patients
    Respiratory Care (2015)
    Shawna L StricklandBruce K. RubinCarl F HaasTeresa A VolskoGail Drescher
    Aerosolized medications are used as airway clearance therapy to treat a variety of airway diseases. These guidelines were developed from a systematic review with the purpose of determining whether the use of these medications to promote airway clearance improves oxygenation and respiratory mechanics, reduces ventilator time and ICU stay, and/or resolves atelectasis/consolidation compared with usual care. Recombinant human dornase alfa should not be used in hospitalized adult and pediatric patients without cystic fibrosis. The routine use of bronchodilators to aid in secretion clearance is not recommended. The routine use of aerosolized N-acetylcysteine to improve airway clearance is not recommended. Aerosolized agents to change mucus biophysical properties or promote airway clearance are not recommended for adult or pediatric patients with neuromuscular disease, respiratory muscle weakness, or impaired cough. Mucolytics are not recommended to treat atelectasis in postoperative adult or pediatric patients, and the routine administration of bronchodilators to postoperative patients is not recommended. There is no high-level evidence related to the use of bronchodilators, mucolytics, mucokinetics, and novel therapy to promote airway clearance in these populations.
    Atelectasis
    Citations (35)